- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04278157
Culturally Centered CBT for Latinx Youth
April 16, 2024 updated by: Bradley Hospital
A Culturally Centered CBT Protocol for Suicidal Ideation and Suicide Attempts Among Latinx Youth
The primary aim of the proposed research is to test the effect of a culturally centered treatment protocol, the Socio-cognitive behavioral therapy (SCBT), versus Treatment as Usual on suicidal thoughts and attempts, and depressive symptoms, in a clinical sample of Latinx adolescents.
The study is trying to determine, if we take into account perspectives of Latin immigrant families and minority youth, whether better outcomes can be found for this high risk group.
Study Overview
Status
Active, not recruiting
Conditions
Detailed Description
The overall goal of this research program is to provide effective culturally relevant care to Latin families, and address the National Institute on Minority Health and Health Disparities (NIMHD) mission of reducing disparities in underserved and minority populations.
Evidence-based and culturally centered treatments for Latinx teens (Latinx = gender inclusive term) with suicidal ideation and attempts (SIA) and their families are quite limited.
Emerging evidence indicate that Cognitive behavioral therapy (CBT) is a promising treatment approach in reducing suicidal ideation and attempts in Non-Latinx White adolescents.
However, culturally adapted treatments have been shown to benefit Latin families more that non-culturally adapted treatments.
This study is innovative in its use of a culturally centered CBT treatment protocol (Socio-Cognitive Behavioral Therapy for Suicidal Behavior-SCBT-SB) to address the specific needs of Latinx teens and their families.
The SCBT-SB, is a modified version of two CBT protocols, which addresses central issues in adolescent identity formation (e.g.
ethnicity, sexual orientation), family interactions and communication, and parenting skills.
The SCBT-SB was developed with Latinx youth with SIA in Puerto Rico and further modified for Latin families in the US.
Feasibility of this modified version of the SCBT-SB was tested in the US by conducting a pilot randomized clinical trial (RCT) (n=46) of SCBT vs treatment-as-usual (TAU) with positive results.
It was found that SCBT-SB was feasible to implement in a community mental health center with frontline therapists, acceptable to families, and showed reductions in suicidal ideation and depressive symptoms.
The scientific premise of the proposed study is that immigration and acculturation (the process of assimilation to the host culture) and enculturation (maintaining cultural values and costumes) experiences have an impact on SIA in Latinx teens; and that personalization of an evidence-based treatment, according to cultural and immigration experiences, will result in better treatment outcomes than TAU.
This application proposes a hybrid efficacy/effectiveness trial with 160 suicidal Latinx teens randomly assigned, following baseline assessment, to 2 treatment conditions, TAU and SCBT-SB.
Follow-up assessment will take place at 3, 6 and 12 months after baseline.
All treatment will take place at a community mental health clinic.
The specific aims are: 1) To test the effect of the SCBT-SB versus TAU on suicidal ideation in a clinical sample of adolescents under conditions of strong external validity, and 2) To test the effect of the SCBT-SB versus TAU on depressive symptoms, given its high correlation with SIA.
Exploratory aims are: 3) To examine the effect of SCBT-SB versus TAU on suicide attempts, and 4) To examine potential mediators (family environment) of treatment outcome.
Successful completion of this study will positively impact treatment of Latinx immigrant adolescents at high risk of SIA in the US.
Study Type
Interventional
Enrollment (Actual)
114
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yovanska Duarte-Velez, PhD
- Phone Number: 401-432-1651
- Email: yovanska.duart-velez@lifespan.org
Study Contact Backup
- Name: Gisela Jimenez-Colon, PhD
- Phone Number: 401-432-1059
- Email: gjimenezcolon@lifespan.org
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Hasbro Children's Hospital (Inpatient Psychiatric Unit)
-
Riverside, Rhode Island, United States, 02915
- Bradley Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 17 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Latinx, defined as have been born in a Latin country or having at least one biological parent, grandparent or an ancestor that was born in a Latin country
- Severe Suicidal Ideation (SI), defined as a score of 22 or above on the SIQ-JR or having made a Suicide Attempts (SA) within the last 3 months
- Caregivers and adolescents fluent in Spanish or English language and legal guardian willing to participate
Exclusion Criteria:
- psychosis
- substance use disorder, rated severe on the DSM-5
- cognitive impairment represented by an IQ below 85
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SCBT-SB
A culturally centered CBT treatment protocol called Socio-Cognitive Behavioral Therapy for Suicidal Behavior (SCBT-SB)
|
The SCBT-SB is a manualized and flexible intervention that uses a modular approach to the treatment of adolescent suicidality.
After the first mandatory module (Crisis module), and at the end of each subsequent module, the therapist works with the teen and caregivers to determine the next one.
The Crisis Module is fixed and represent the intervention core skills with 9 sessions.
The optional coping skills modules include Thoughts, Emotional Regulation, Family Communication, Social Interaction, Activity, Trauma, and Substance Use.
|
Active Comparator: Treatment as Usual
Treatment as usual is base on the standard care for teens and their parents under a community mental health center.
|
Therapy that typically consist of eclectic individual therapy including CBT, emphasizing psychoeducation and providing support, with occasional conjoint parent sessions or individual caregiver sessions.
The treatment as usual primarily focuses on generating solutions to the adolescent and caregivers most urgent concerns.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Suicidal ideation
Time Frame: Change from baseline to 3 month, 6 month, and 12 month follow up points.
|
Suicidal ideation measured using the Suicide Ideation Questionnaire-Junior (SIQ-JR), the minimum score is 0 and the maximum 90.
A higher score represents increase severity and frequency of suicidal thoughts.
|
Change from baseline to 3 month, 6 month, and 12 month follow up points.
|
Depressive symptoms by self-report
Time Frame: Change from baseline to 3 month, 6 month, and 12 month follow up points.
|
Level of depressive symptomatology using the Children Depression Inventory 2 (CDI-2), the minimum score is 0 and the maximum 56.
A higher score means higher level of depressive symptoms.
|
Change from baseline to 3 month, 6 month, and 12 month follow up points.
|
Depressive symptoms by clinical interview
Time Frame: Change from baseline to 3 month, 6 month, and 12 month follow up points.
|
Depressive symptoms using the Children's Depression Rating Scale-Revised (CDRS-R), the minimum raw score is 17 and the maximum 113.
A higher score means higher level of depressive symptoms.
|
Change from baseline to 3 month, 6 month, and 12 month follow up points.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Suicide Attempts
Time Frame: Change from baseline to 6 months follow-up
|
Number of total actual and interrupted suicide attempts using the Columbia-Suicide Severity Rating Scale (C-SSRS)
|
Change from baseline to 6 months follow-up
|
Suicide Attempts
Time Frame: Change from 6 months to 12 months follow-up
|
Actual and interrupted suicide attempts (yes or no) using the Columbia-Suicide Severity Rating Scale (C-SSRS)
|
Change from 6 months to 12 months follow-up
|
Suicide Attempts
Time Frame: Change from baseline to 12 months follow-up
|
Actual and interrupted suicide attempts (yes or no) using the Columbia-Suicide Severity Rating Scale (C-SSRS)
|
Change from baseline to 12 months follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Yovanska Duarte-Velez, PhD, Bradley Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 2, 2020
Primary Completion (Estimated)
January 31, 2025
Study Completion (Estimated)
July 31, 2025
Study Registration Dates
First Submitted
February 13, 2020
First Submitted That Met QC Criteria
February 18, 2020
First Posted (Actual)
February 20, 2020
Study Record Updates
Last Update Posted (Actual)
April 17, 2024
Last Update Submitted That Met QC Criteria
April 16, 2024
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1437564-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Data will be made available to other researchers by request and as per NIH data sharing guidelines.
The PI will also consult to anyone interested in replicating the intervention and study.
IPD Sharing Time Frame
One year following collection and final analyses.
IPD Sharing Access Criteria
By email contact with PI.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Suicide
-
Syeda AYAT E ZAINAB AliUniversity of Leicester; University of WuerzburgRecruitingSuicide, Attempted | Suicide | Suicide Prevention | Completed SuicidePakistan
-
Seattle Children's HospitalNationwide Children's HospitalRecruitingSuicidal Ideation | Suicide Threat | Suicide and Self-harm | Suicide AttemptsUnited States
-
Vestre Viken Hospital TrustSouth-Eastern Norway Regional Health AuthorityRecruitingEcological Momentary Assessment | Suicide Risk | Suicide Attempt | Suicide Ideation | Suicide PreventionNorway
-
Mental Health Services in the Capital Region, DenmarkCompletedSuicide Prevention | Suicidal Thoughts | Suicide AttemptsDenmark
-
VA Office of Research and DevelopmentNot yet recruitingSuicidal Ideation | Suicide Attempt | Suicide PreventionUnited States
-
Franciscan Hospital For Children, INC.National Institute of Mental Health (NIMH); Harvard UniversityRecruitingSuicidal Ideation | Self-Injurious Behavior | Suicide AttemptsUnited States
-
Boston UniversityUnited States Department of Defense; The University of Texas Health Science... and other collaboratorsNot yet recruiting
-
Kaiser PermanenteNational Institute of Mental Health (NIMH); Henry Ford Health System; HealthPartners...Enrolling by invitationSuicide, Attempted | Suicide, FatalUnited States
-
University Hospital, MontpellierINSERM U960 - Cognitive Neuroscience Laboratory - Paris, FranceTerminatedDepression | History of Suicide AttemptFrance
Clinical Trials on Socio-Cognitive Behavioral Therapy for Suicidal Behavior (SCBT-SB)
-
VA Office of Research and DevelopmentCompleted
-
VA Office of Research and DevelopmentRecruitingMajor Depressive Disorder | Posttraumatic Stress Disorder | Panic Disorder and AgoraphobiaUnited States
-
University of California, San DiegoNational Institute of Mental Health (NIMH)CompletedAnxiety Disorders | Generalized Anxiety Disorder | Panic Disorder
-
VA Office of Research and DevelopmentRecruitingSocial Anxiety DisorderUnited States
-
Ohio State University Comprehensive Cancer CenterAmerican Cancer Society, Inc.; Lance Armstrong FoundationCompletedDepression | Pain | Leukemia | Fatigue | Multiple Myeloma | Insomnia | Pancreatic Cancer | Esophageal Cancer | Lung Cancer | Glioblastoma Multiforme | Sleep Disorders | Uncertainty | Ovarian Neoplasm | Anxiety Disorder | Psychological Intervention | Relapsed Lymphoma | Worry | Cognitive-behavioral Therapy | Stage III or IV Cervical... and other conditionsUnited States
-
Stanford UniversityNot yet recruitingSuicide and Self-harmUnited States
-
University GhentCompletedSuicidal Ideation | Suicide AttemptBelgium
-
State University of New York at BuffaloNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Northwestern... and other collaboratorsCompletedIrritable Bowel SyndromeUnited States
-
Tricia VauseOntario Ministry of Health and Long Term Care; Ontario Mental Health FoundationCompletedAutism Spectrum Disorder | Obsessive-Compulsive BehaviorCanada
-
VA Office of Research and DevelopmentUniversity of MichiganCompletedChronic Low Back PainUnited States